Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eziclen vs Fortrans for Bowel Cleansing (ESTOS)
NCT02321462Phase 3Completed
- Sponsor
- Ipsen
- Start
- Mar 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of sodium sulfate + potassium sulfate + magnesium sulfate in Gastrointestinal cleansing (2 arms), sponsored by Ipsen. Primary endpoint: Adjusted Percentage of Patients With Successful Overall Colon Preparation, Assessed by the Global Score of the Boston Bowel Preparation Scale (BBPS) at Day 2. Started Mar 2015; status: completed.
02
Drugs
sodium sulfate + potassium sulfate + magnesium sulfate
03
Conditions
Gastrointestinal cleansing
Beyond the preview
Go deeper on NCT02321462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02321462.